(Q27851560)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20368568%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

1 reference

Phase II clinical trial of sorafenib in metastatic medullary thyroid cancer (English)

2 references

13 November 2016

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20368568%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

main subject

phase II clinical trial

0 references

1 reference

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20368568%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

author name string

Elaine T Lam

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20368568%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Matthew D Ringel

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20368568%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Richard T Kloos

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20368568%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Thomas W Prior

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20368568%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Michael V Knopp

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20368568%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Jiachao Liang

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20368568%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Nathan C Hall

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20368568%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Paul E Wakely

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20368568%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Vasyl V Vasko

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20368568%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Motoyasu Saji

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20368568%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Pamela J Snyder

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20368568%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Lai Wei

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20368568%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Daria Arbogast

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20368568%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Minden Collamore

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20368568%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

John J Wright

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20368568%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Jeffrey F Moley

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20368568%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Miguel A Villalona-Calero

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20368568%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Manisha H Shah

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20368568%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

language of work or name

English

0 references

publication date

5 April 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20368568%20AND%20SRC:MED&resulttype=core&format=json

Journal of Clinical Oncology

30 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20368568%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

volume

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20368568%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

page(s)

2323-2330

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20368568%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

issue

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20368568%20AND%20SRC:MED&resulttype=core&format=json

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

30 January 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2881718

BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2881718

Phase II study of safety and efficacy of motesanib in patients with progressive or symptomatic, advanced or metastatic medullary thyroid cancer.

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2881718

New targets and therapeutic approaches for endocrine malignancies

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2881718

Phase II trial of sorafenib in metastatic thyroid cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2881718

Axitinib is an active treatment for all histologic subtypes of advanced thyroid cancer: results from a phase II study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2881718

Phase II trial of sorafenib in advanced thyroid cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2881718

Medullary thyroid cancer: targeting the RET kinase pathway with sorafenib/tipifarnib

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2881718

Thyroid carcinoma: molecular pathways and therapeutic targets

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2881718

The RET kinase inhibitor NVP-AST487 blocks growth and calcitonin gene expression through distinct mechanisms in medullary thyroid cancer cells

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2881718

Apoptotic cell death induction and angiogenesis inhibition in large established medullary thyroid carcinoma xenografts by Ret inhibitor RPI-1.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2881718

BAY 43-9006 inhibition of oncogenic RET mutants

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2881718

Expression of angiogenesis stimulators and inhibitors in human thyroid tumors and correlation with clinical pathological features

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2881718

The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2881718

Treatment of advanced medullary thyroid cancer with an alternating combination of 5 FU-streptozocin and 5 FU-dacarbazine. The Groupe d'Etude des Tumeurs a Calcitonine (GETC)

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2881718

Advances in the diagnosis and treatment of medullary thyroid carcinoma.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2881718

Optimal two-stage designs for phase II clinical trials

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2881718

Sometimes size doesn't matter: reevaluating RECIST and tumor response rate endpoints.

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2881718

Medullary thyroid carcinoma

27 November 2018

1 reference

12 December 2020

Will there be resistance to the RECIST (Response Evaluation Criteria in Solid Tumors)?

1 reference

12 December 2020

Prognostic value of codon 918 (ATG-->ACG) RET proto-oncogene mutations in sporadic medullary thyroid carcinoma

1 reference

12 December 2020

Phase II placebo-controlled randomized discontinuation trial of sorafenib in patients with metastatic renal cell carcinoma

1 reference

12 December 2020

Identifiers

DOI

10.1200/JCO.2009.25.0068

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20368568%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

1 reference

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20368568%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

2 references